Cite
HARVARD Citation
Kuwana, M. et al. (2023). Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo‐controlled, double‐blind, parallel‐group study. British journal of haematology. pp. 802-811. [Online].